SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-053060
Filing Date
2024-04-26
Accepted
2024-04-26 16:59:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2412804d2_defa14a.htm DEFA14A 13174
2 GRAPHIC tm2412804d2_defa14aimg001.jpg GRAPHIC 258165
3 GRAPHIC tm2412804d2_defa14aimg002.jpg GRAPHIC 118400
  Complete submission text file 0001104659-24-053060.txt   533267
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36598 | Film No.: 24884917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)